{
  "retracted": false,
  "timestamp": 1559692800000,
  "updates": [
    {
      "timestamp": 1561385446348,
      "identifier": {
        "doi": "10.1007/s11060-019-03201-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s11060-019-03194-z"
  },
  "journal": "Journal of Neuro-Oncology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)"
}
